Drug Interaction Study With Rifampicin and Afatinib
Clinical trial NCT01396265 · COMPLETED
Trial details
- NCT number
- NCT01396265
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-01
- Primary completion
- 2011-08-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.